SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

75,577.58 -555.23
( -0.73%)

Global Indices

Nasdaq

53,435.25 -271.85
(-0.51%)

Dow Jones

7,739.60 -29.11
(-0.37%)

Hang Seng

65,678.73 -721.11
(-1.09%)

Nikkei 225

10,817.95 -13.14
(-0.12%)

Forex

USD-INR

94.44 -0.05
(-0.05%)

EUR-INR

109.67 -0.05
(-0.04%)

GBP-INR

127.62 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Acutaas Chemicals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

543349

INE00FF01025

203.7821787

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ACUTAAS

65.54

26047.71

EPS(TTM)

Face Value()

Div & Yield %

48.54

0.08

Back

veljan denison ltd

Banas Finance consolidated net profit declines 53.25% in the June 2026 quarter

Aug 15,2026

Net profit of Banas Finance declined 53.25% to Rs 4.97 crore in the quarter ended June 2026 as against Rs 10.63 crore during the previous quarter ended June 2025. Sales declined 84.66% to Rs 2.99 crore in the quarter ended June 2026 as against Rs 19.49 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	2.99	19.49	-85
OPM %	95.99	48.38	-
PBDT	2.87	9.56	-70
PBT	2.87	9.55	-70
NP	4.97	10.63	-53

75,577.58 -555.23 ( -0.73%)

53,435.25 -271.85 (-0.51%)

7,739.60 -29.11 (-0.37%)

65,678.73 -721.11 (-1.09%)

10,817.95 -13.14 (-0.12%)

94.44 -0.05 (-0.05%)

109.67 -0.05 (-0.04%)

127.62 -0.01 (-0.01%)

0.60 0.00 (0.12%)